BD Pioneers New Standard in Surgical Safety with FDA-Cleared Surgiphor™ 1000mL for Wound Irrigation

The first and only innovation of its kind to receive 510(k) clearance, Surgiphor™ 1000mL empowers surgical teams with a consistent, antimicrobial solution designed to improve patient care and operating room (OR) efficiency

FRANKLIN LAKES, N.J.,March 2, 2026/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Surgiphor™ 1000mL. As the first and only 1000 mL antimicrobial irrigation system specifically designed for powered lavage, Surgiphor™ 1000mL provides a standardized, OR-ready solution that enhances surgical safety and efficacy.

This latest addition to the Surgiphor™ portfolio empowers clinicians to mechanically loosen and remove debris and microorganism from wounds within powered irrigation workflows. By simplifying these complex procedures, Surgiphor™ 1000mL delivers the consistency, efficiency, and ease of use across a broad range of complex surgical procedures.

arrives ready-to-use and completely sterile, eliminating the need for hospital staff to mix solutions by hand. This saves valuable time in the operating room while helping hospitals meet global safety guidelines for surgical wound cleaning.

"This FDA clearance reinforces BD's position as the global leader in surgical irrigation innovation," said Rian Seger, worldwide president of the BD Surgery business. "Surgiphor™ 1000mL is a unique solution that provides the consistency and safety surgical teams expect from BD, allowing them to focus on what matters most: providing better, safer care for their patients."

Building on the adoption of the original Surgiphor™ system, the Surgiphor™ 1000mL configuration gives operating room teams a larger-volume option engineered to fit seamlessly into existing powered irrigation setups.

The expanded Surgiphor™ portfolio now offers both manual and powered irrigation configurations, giving clinicians flexibility to match the needs of their workflow and patient population. For more information about Surgiphor™ 1000mL or the Surgiphor™ Antimicrobial Irrigation System, visit bd.com/surgiphorsystem.

BD is one of the world's largest pure-play medical technology companies with a Purpose ofadvancing the world of health™by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more information on BD, please visitbd.comor connect with us on LinkedIn atwww.linkedin.com/company/bd1/, X@BDandCoor Instagram@becton_dickinson.